Archive
XP Power sparks as orders rise despite semiconductor slowdown
A look at some of the major risers and fallers in London on Thursday
Company
LON:AVCT
At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.
207 stories · page 3 of 11
Archive
A look at some of the major risers and fallers in London on Thursday
The two firms will join forces to develop drug conjugates based on Avacta’s Affimer rather than standard antibodies
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Premier Technical, Evraz, Gunsynd, Dixons Carphone, Serabi Gold and EVR
On the tie-up with Selexis, Avacta chief executive Alastair Smith said the company's new partner provided “the technology and know-how” to develop the required cell lines for the planned first-in-human study
Investments and investor services
Carnival and Evra were the two big fallers among Footsie constituents
Archive
A look at the day's major movers, including Ted Baker, IAG, easyJet, Bagir, Blue Prism, EVR, Blackbird, Nu-Oil & Gas, Anglo Asian Mining and Petrel Resources
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
All eyes will be on the statement from Fed rate setters later, especially due to the pressure to lower rates from President Trump
Archive
A look at the day's major movers, including Helical, Ocado, Thomas Cook, Scapa, Dods Group, Rockfire Resources and Avesoro Resources
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The important milestone puts the company on track to file a new drug/clinical application by the end of 2020 as planned
Investments and investor services
The UK's index of leading shares finished the first day of the trading week around 46 points higher at 7,378
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Carclo, Sareum, Karelian, Kier, Fulcrum, Microsaic, Dignity and Scapa
The group's technology releases chemo directly inside a tumour without exposing the whole body to toxins
Investments and investor services
The UK's blue-chip benchmark added over 23 points to close at 7,184